Xarelto, or rivaroxaban, is a blood thinning medication initially approved by the FDA for the prevention of deep vein thrombosis. Today, it is marketed for treatment of blood clots and for stroke prevention and is portrayed as superior to warfarin. Xarelto can cause irreversible internal bleeding that can lead to hospitalization and death. If you or a loved one has experienced complications related to Xarelto, please contact us.

Other Practices Under Defective Products